Home » Topics » BioWorld Science

BioWorld Science
RSS

Enesi and NIAID enter agreement to study ImplaVax-enabled pandemic flu vaccine

Oct. 19, 2021

NCI awards SBIR grant to Orphagen to develop OR-449 for adrenocortical carcinoma

Oct. 19, 2021

Nordic Nanovector and University of Pennsylvania establish CD37-targeting CAR-T cell collaboration

Oct. 19, 2021

PDE9 inhibition shows preclinical promise for the treatment of obesity and cardiometabolic syndrome

Oct. 19, 2021

Hygromycin A clears B. burgdorferi infection in mice

Oct. 19, 2021

Atsena discloses preclinical gene therapy program for X-linked retinoschisis

Oct. 19, 2021

CELSR2 regulates lipid homeostasis and it is a therapeutic target in NAFLD

Oct. 19, 2021

Orexia and Schrodinger collaborate to discover novel therapeutics targeting OX2 receptor

Oct. 19, 2021

CoImmune and MSK collaborate to adapt CAR-CIK technology to treat solid tumors

Oct. 19, 2021

Cannabidiol-carbamate hybrid shows therapeutic potential in models of AD

Oct. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...